Goldenwell BiotechGWLL 30 Quick Ratio is 0.19 as of Mar. 2026, which is 91% below its 10-year median of 2.03. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,990 Consumer Packaged Goods companies, Goldenwell Biotech ranks worse than 95.28% on this metric.
Goldenwell Biotech has a quick ratio of 0.19. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Goldenwell Biotech's Quick Ratio or its related term are showing as below:
GWLL'
s Quick Ratio Range Over the Past 10 Years
Min: 0.19 Med: 2.03 Max: 44
Current: 0.19
During the past 6 years, Goldenwell Biotech's highest Quick Ratio was 44.00. The lowest was 0.19. And the median was 2.03.
GWLL's Quick Ratio is ranked worse than 95.28% of 1990
companies
in the Consumer Packaged Goods industry
Industry Median: 1.12
vs GWLL: 0.19
Goldenwell Biotech (OTCPK:GWLL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Goldenwell Biotech Quick Ratio Related Terms
Goldenwell Biotech Quick Ratio Historical Data
* Premium members only.
The historical data trend for Goldenwell Biotech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Goldenwell Biotech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Goldenwell Biotech Quick Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Goldenwell Biotech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Goldenwell Biotech's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Goldenwell Biotech (GWLL) has a Quick Ratio of 0.19 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Goldenwell Biotech and its competitors. This is 91% below median its historical median of 2.03. Over the past decade, Goldenwell Biotech's Quick Ratio has ranged from 0.19 to 44.00. According to the industry distribution chart, Goldenwell Biotech ranks #1896 out of 1990 companies in the Consumer Packaged Goods industry, placing it in the top 95.3%.
Is Goldenwell Biotech's Quick Ratio too high?
Goldenwell Biotech's current Quick Ratio of 0.19 is 91% below median its 10-year median of 2.03. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 44.00. The Consumer Packaged Goods industry median Quick Ratio is 1.12. Goldenwell Biotech's value of 0.19 is 83% below this industry median. Based on the distribution chart, Goldenwell Biotech ranks #1896 out of 1990 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's Quick Ratio compare to HAIN and LSF?
According to the Consumer Packaged Goods industry distribution chart, Goldenwell Biotech ranks #1896 out of 1990 companies for Quick Ratio. This places Goldenwell Biotech in the lower half of its industry. The industry median Quick Ratio is 1.12. Goldenwell Biotech's value of 0.19 is 83% below this benchmark. Historically, Goldenwell Biotech's own Quick Ratio has ranged from 0.19 to 44.00 over the past decade. While the company's 10-year median is 2.03 vs. the industry median of 1.12, Goldenwell Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Consumer Packaged Goods company?
The median Quick Ratio among Consumer Packaged Goods companies is 1.12, based on 1,990 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Goldenwell Biotech's current Quick Ratio of 0.19 is 83% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Goldenwell Biotech and its competitors. For the Consumer Packaged Goods industry, the median Quick Ratio is 1.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Goldenwell Biotech's current Quick Ratio is 0.19, which is 91% below median its own 10-year median of 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current Quick Ratio of 0.19. The current Quick Ratio is 0.19, which is 91% below median its 10-year median of 2.03 and 83% below the Consumer Packaged Goods industry median of 1.12. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current Quick Ratio is 0.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score
Get the complete analysis for GWLL
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWLL has been successfully added to your 
